Janet Huang Pulskamp, MD
Obstetrics & Gynecology · Mountain View
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Pulskamp’s office at (650) 988-7550 to ask if they take your plan before you enroll.
California Medical Board record
Licence G74201 · Current
Licensed to practise in California · since 1992 · expires 2027-12-31 · University of California, San Diego School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Obstetrics and Gynecology - Obstetrics and Gynecology
Medicaid work
$0 in 2024
Medicaid paid $0 for 14 billed services this clinician did in 2024, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| TOBACCO NON-USER | 14 | $0 |
| 2024 | 14 | 1 | 14 | $0 |
Drugs they prescribed that Part D paid
$39,562
Pharmacies billed $39,562 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
237 generic and 65 brand-name prescriptions · $39,562 in drug cost · 12 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estring | 42 | $25,694 | $612 |
| Estradiol | 97 | $4,431 | $46 |
| Yuvafem | 38 | $3,835 | $101 |
| Climara | 11 | $1,394 | $127 |
| Progesterone | 11 | $479 | $44 |
See all 7 drugs
| Estring | 42 | $25,694 | $612 |
| Estradiol | 97 | $4,431 | $46 |
| Yuvafem | 38 | $3,835 | $101 |
| Climara | 11 | $1,394 | $127 |
| Progesterone | 11 | $479 | $44 |
| Acyclovir | 17 | $474 | $28 |
| Clobetasol Propionate | 16 | $245 | $15 |
Year by year
| 2024 | 302 | 127 | None | 22% | $39,562 |
| 2023 | 238 | 114 | None | 18% | $25,887 |
| 2022 | 147 | 81 | 0% (0) | 25% | $20,535 |
| 2021 | 210 | 108 | 0% (0) | 25% | $27,223 |
| 2020 | 215 | 102 | 0% (0) | 22% | $26,622 |
| 2019 | 196 | 101 | None | 27% | $32,136 |
| 2018 | 204 | 98 | None | 32% | $34,357 |
| 2017 | 238 | 109 | None | None | $51,868 |
| 2016 | 235 | 103 | None | 44% | $47,527 |
| 2015 | 276 | 124 | None | 40% | $46,282 |
| 2014 | 236 | 104 | None | 36% | $30,027 |
| 2013 | 230 | 107 | 5% (11) | 32% | $27,462 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Estring | 25 | $14,778 | $591 |
| Estradiol | 88 | $4,023 | $46 |
| Yuvafem | 24 | $2,905 | $121 |
| Acyclovir | 20 | $764 | $38 |
| Clobetasol Propionate | 20 | $321 | $16 |
2022: 4 drugs
| Estring | 23 | $13,007 | $566 |
| Yuvafem | 18 | $2,811 | $156 |
| Estradiol | 57 | $2,517 | $44 |
| Acyclovir | 17 | $700 | $41 |
2021: 4 drugs
| Estring | 31 | $17,047 | $550 |
| Estradiol | 86 | $4,796 | $56 |
| Yuvafem | 12 | $1,784 | $149 |
| Acyclovir | 24 | $879 | $37 |
2020: 3 drugs
| Estring | 31 | $16,497 | $532 |
| Estradiol | 92 | $5,587 | $61 |
| Acyclovir | 21 | $776 | $37 |
2019: 5 drugs
| Estring | 29 | $14,786 | $510 |
| Estrace | 22 | $6,090 | $277 |
| Yuvafem | 14 | $4,134 | $295 |
| Estradiol | 53 | $2,498 | $47 |
| Acyclovir | 11 | $294 | $27 |
2018: 4 drugs
| Estring | 36 | $17,511 | $486 |
| Estrace | 58 | $7,245 | $125 |
| Oxybutynin Chloride Er | 11 | $589 | $54 |
| Acyclovir | 17 | $490 | $29 |
2017: 6 drugs
| Estring | 46 | $20,200 | $439 |
| Estrace | 55 | $17,265 | $314 |
| Yuvafem | 14 | $4,474 | $320 |
| Climara | 11 | $1,443 | $131 |
| Acyclovir | 14 | $402 | $29 |
| Medroxyprogesterone Acetate | 11 | $280 | $25 |
2016: 6 drugs
| Estrace | 49 | $14,822 | $302 |
| Estring | 38 | $13,778 | $363 |
| Vagifem | 14 | $6,681 | $477 |
| Premarin | 15 | $4,701 | $313 |
| Acyclovir | 12 | $428 | $36 |
| Estradiol | 11 | $300 | $27 |
2015: 8 drugs
| Estrace | 61 | $15,418 | $253 |
| Estring | 30 | $9,165 | $306 |
| Vagifem | 20 | $8,109 | $405 |
| Premarin | 14 | $3,470 | $248 |
| Clobetasol Propionate | 11 | $1,140 | $104 |
| Acyclovir | 17 | $715 | $42 |
| Metronidazole | 13 | $160 | $12 |
| Misoprostol | 15 | $152 | $10 |
2014: 6 drugs
| Estrace | 52 | $10,841 | $208 |
| Estring | 21 | $5,648 | $269 |
| Premarin | 17 | $3,373 | $198 |
| Acyclovir | 12 | $348 | $29 |
| Metronidazole | 11 | $285 | $26 |
| Estradiol | 12 | $211 | $18 |
2013: 4 drugs
| Estrace | 58 | $10,989 | $189 |
| Estring | 20 | $4,894 | $245 |
| Acyclovir | 17 | $518 | $30 |
| Estradiol | 18 | $410 | $23 |
Professional record
- NPI
- 1982735650
- Licence
- CA G74201California G74201: Current · expires 2027-12-31
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 2485 Hospital Dr, Suite 221, Mountain View, CA, 94040
- NPI first listed
- 2007-03-07
- NPI last updated
- 2021-12-15
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.